image

The best stocks to buy since 1993

Our latest issue will be released in 12 days, don't miss out!

SIGN UP NOW
Updates

Kooth

November 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • KOO
  • Price:
  • 300p
Kooth’s interims are largely of academic interest given that Kooth signed the transformational US$188m+ California contract in July. The keynote is that the US platform has already been built and a beta version has soft launched in two California counties. It is on track for the full launch of its App and support infrastructure in January.    H1 22 revenue grew 29% to £11.7m and EBITDA was flat as expected due to the ramp up in costs to support the US launch. Annualised recurring revenue (ARR) grew 16% over the prior year to £21.4m. UK revenues increased 9% to £9.8m with new contract wins in CYP and 52% of contracts being expanded on renewal, offset by increased churn, particularly in UK Adult where some pilot contracts wer ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Kooth - £150m contract win (August 2023)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW